Clinical trial
Splicing-Based Predictive Learning for Individual Chemotherapy Evaluation in Colorectal Cancer (SPLICE)
NCT07226115 is registered in ClinicalTrials.gov with City of Hope Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Splicing-Based Predictive Learning for Individual Chemotherapy Evaluation in Colorectal Cancer (SPLICE)
- Lead sponsor
- City of Hope Medical Center
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- June 21, 2024
- Completion date
- June 18, 2028
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
colorectal cancer, colorectal cancer recurrent, colorectal cancer stage ii, colorectal cancer stage iii